Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases. Founded in 2018, Atalanta Therapeutics is backed by investors that include F-Prime Capital and is headquartered in Boston.
FOUNDED:
2018
INDUSTRY:
Biotechnology, Life Science
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
